GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Oracle Healthcare Acquisition Corp (OTCPK:OHAQ) » Definitions » Shares Outstanding (EOP)

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Shares Outstanding (EOP) : 18.75 Mil (As of Dec. 2007)


View and export this data going back to 2006. Start your Free Trial

What is Oracle Healthcare Acquisition Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Oracle Healthcare Acquisition's shares outstanding for the quarter that ended in Dec. 2007 was 18.75 Mil.

Oracle Healthcare Acquisition's quarterly shares outstanding stayed the same from Sep. 2007 (18.75 Mil) to Dec. 2007 (18.75 Mil).

Oracle Healthcare Acquisition's annual shares outstanding stayed the same from Dec. 2006 (18.75 Mil) to Dec. 2007 (18.75 Mil).


Oracle Healthcare Acquisition Shares Outstanding (EOP) Historical Data

The historical data trend for Oracle Healthcare Acquisition's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oracle Healthcare Acquisition Shares Outstanding (EOP) Chart

Oracle Healthcare Acquisition Annual Data
Trend Dec05 Dec06 Dec07
Shares Outstanding (EOP)
3.75 18.75 18.75

Oracle Healthcare Acquisition Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07
Shares Outstanding (EOP) Get a 7-Day Free Trial 18.75 18.75 18.75 18.75 18.75

Competitive Comparison of Oracle Healthcare Acquisition's Shares Outstanding (EOP)

For the Medical Care Facilities subindustry, Oracle Healthcare Acquisition's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oracle Healthcare Acquisition's Shares Outstanding (EOP) Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Oracle Healthcare Acquisition's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Oracle Healthcare Acquisition's Shares Outstanding (EOP) falls into.



Oracle Healthcare Acquisition Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Oracle Healthcare Acquisition  (OTCPK:OHAQ) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Oracle Healthcare Acquisition Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Oracle Healthcare Acquisition's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
Website
Executives
Andrew M Weiss 10 percent owner 222 BERKELEY STREET, 16TH FLOOR, BOSTON MA 02116
Jeffrey Tannenbaum 10 percent owner 505 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10017
Fir Tree Inc. 10 percent owner 500 FIFTH AVENUE, 9TH FLOOR, NEW YORK NY 10110
Camellia Partners, Llc 10 percent owner 51 BEDFORD ROAD, SUITES 3 & 4, KATONAH NY 10536
Andrew Fredman 10 percent owner 7301 SW 57TH COURT, SUITE 410, SOUTH MIAMI FL 33143
Fir Tree, L.l.c. 10 percent owner 505 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10017
Per Gh Lofberg director C/O MERCK CAPITAL VENTURES, 50 TICE BLVD, WOODCLIFF NJ 07677
Larry N Feinberg director, 10 percent owner C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
George Bickerstaff director C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Kevin C Johnson director 12 KEELERS RIDGE ROAD, WILTON CT 06897
Mark A Radzik officer: CFO & Secretary
Joel D Liffman director, officer: President and COO C/O ORACLE STRATEGIES PARTNERS, L.P., 712 FIFTH AVENUE, 45TH FLOOR, NEW YORK NY 10019

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Headlines

No Headlines